ICRC-Weyer GmbH

MEDIS RESEARCH GROUP, a strategic alliance of Berlin-based clinical research organizations, has recently been joined by yet another CRO from the Berlin area, oncology specialists ONKODATAMED GmbH.

The Berlin-based clinical contract research organizations, ICRC-Weyer and Allied Clinical Management, have announced that they have entered into a strategic alliance, as part of the newly founded MEDIS Research Group.

ICRC-Weyer GmbH, a Berlin-based clinical contract research organization, is expanding its pharmacovigilance services for small to mid-sized pharmaceutical companies.

The Berlin-based clinical contract research organization (CRO), ICRC-Weyer GmbH, has announced it will boost its drug-safety related Pharmacovigilance Services for Investigator-Initiated Trials amid an increasing demand by trial sponsors.

ICRC-Weyer GmbH, a German clinical contract research organization (CRO), has expanded its data management team and recently joined the Clinical Data Interchange Standards Consortium (CDISC®) on a gold-level...

The German clinical contract research organization (CRO), ICRC-Weyer GmbH, is extending their Medical Writing Services with specialized Pharmacovigilance Writing, a comprehensive solution for regulatory-compliant drug safety reporting.

The Berlin-based clinical contract research organization (CRO) ICRC-Weyer GmbH is adapting a process of integrating medical review procedures into Pharmacovigilance risk management, a method that will lead to better Pharmacovigilance practices.

ICRC-Weyer GmbH, a clinical contract research organization (CRO) based in Berlin, Germany, has released its review of the year 2012, stating it has been a successful and exciting 12 months for everybody involved in the business.

The German clinical contract research organization (CRO) ICRC-Weyer GmbH has announced that the company is prepared for the increasing number of Advanced Therapy trials, a trend that is expected to continue for the next 10 to 15 years.

Innovation in drug development requires flexibility in the clinical trial design, not merely standardisation, according to Prof Dr Geerd Weyer, Managing Director at ICRC-Weyer clinical contract research organisation.